Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
alzheimer's disease
5
×
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
cancer immunotherapy
detroit blog main
detroit top stories
indiana blog main
indiana top stories
investing
5
×
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
pfizer
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
startups
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
deals
fda
regeneron pharmaceuticals
amag pharmaceuticals
arch venture partners
astrazeneca
biogen
cancer
What
bio
5
×
roundup
alzheimer’s
amid
bombast
cancer
caught
coronavirus
debate
develop
discussion
drug
efforts
meso’s
miss
pandemic
pfizer’s
presidential
prices
promise
response
tuesday’s
vaccine
viewers
alliance
annual
assessed
attention
biotech
bristol
buy
calls
changing
color
communities
companies
conference
crispr
days
different
Language
unset
Current search:
investing
×
bio
×
" alzheimer's disease "
×
@xconomy.com
3 years ago
Bio Roundup: CRISPR Kudos, Bristol Myers’s Buy, RNAi Alliance & More
@xconomy.com
3 years ago
Bio Roundup: MESO’s Miss, Pfizer’s Cancer Bet, Vaccine Promise & More
@xconomy.com
3 years ago
Bio Roundup: MESO’s Miss, Pfizer’s Cancer Bet, Vaccine Promise & More
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Fail, Drug Price Plan, Gene Therapies & More
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Puzzle, ESMO Assessed, Drug Prices & More
